ARCHIVES

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

This article is from The Cancer Letter archive.

Vol. 23 No. 05 | February 7, 1997

Download PDF Visit The Full Archive

Related Articles

President’s Cancer Panel Lists Recommendations For Improving Quality Of Cancer Care

April 9, 1999

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

NCI Releases 550 Pages of Internal Documents Related To Duke Scandal

January 7, 2011

NCI Opens Negotiations With Litton-Bionetics For Renewal of $10 Million Frederick Contract

March 1, 1974

Cancer Program Depend On Vitality Of Centers, Broder ells DCPC Board

May 12, 1989

Two Breast Cancer Screening Methods Found Equivalent

August 29, 2008